YOLFTbeta
Eyebright Medical Technology Beijing Co Ltd

Eyebright Medical Technology Beijing Co Ltd

688050 · SHG · Healthcare / Medical Instruments & Supplies

41.46CNY-0.50 (-1.19%)

Price History

Full chart

Market Stats

Previous Close41.96
Open42.20
Day Range41.43 – 43.44
52-Week Range35.23 – 74.26
Volume3.14M
Market Cap7.51B
P/E (TTM)31.80
Forward P/E0.00
EPS1.22
Dividend Yield0.82%
Beta0.20
50-Day Avg39.98
200-Day Avg48.71

About

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company provides intraocular lens, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also offers solutions for ophthalmic surgery, refractive error correction, and optometry consumption. The company was founded in 2010 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jiangbing Xie
  • Employees2.66K
  • HeadquartersScience and Technology Park, Beijing, China, 102200, China
  • Websitehttps://www.ebmedical.com

Leadership

  • Mr. Jiangbing XieChairman of the Board, GM & Chief Scientist · b. 1972
  • Mr. Yanchang GuoDeputy GM, CFO, Financial Director & Accounting Supervisor · b. 1979
  • Ms. Shaohua WangSenior VP & Director of Operations · b. 1970
  • Mr. Baoshan JiaDeputy GM, National Marketing & Sales Director and Director · b. 1979
  • Ms. Zhao WangDeputy GM, R&D Director & Director · b. 1981
  • Ms. Yuqian ZhouAssistant to the GM & Board Secretary · b. 1987
  • Ms. Shuyan GuoR&D Project Manager · b. 1983
  • Ms. Jie YuR&D Project Manager · b. 1987
  • Ms. Danxuan WangSenior Human Resources Manager · b. 1982

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue43.53M74.81M126.97M195.20M273.05M433.07M579.50M951.18M1.41B1.48B
Growth (%)-+71.86%+69.72%+53.73%+39.88%+58.61%+33.81%+64.14%+48.24%+5.15%
Cost of Revenue12.39M18.62M23.77M27.82M43.97M68.08M88.35M230.04M479.83M541.29M
Gross Profit31.14M56.19M103.20M167.38M229.08M364.99M491.15M721.14M930.19M1.48B
Gross Margin71.54%75.11%81.28%85.75%83.90%84.28%84.75%75.82%65.97%100.00%
Operating Expense40.99M59.35M76.44M97.72M117.82M180.00M231.88M393.69M497.19M1.19B
Operating Income-9.85M-3.16M26.75M69.66M111.26M184.99M259.27M327.45M433.00M289.94M
Operating Margin-22.64%-4.22%21.07%35.68%40.75%42.72%44.74%34.43%30.71%19.55%
EBITDA3.50M6.47M41.89M92.27M137.76M218.78M305.99M410.01M580.20M417.66M
EBITDA Margin8.04%8.65%32.99%47.27%50.45%50.52%52.80%43.11%41.15%28.17%
Net Income-1.40M-4.11M20.31M66.69M96.56M171.34M232.69M303.98M388.40M265.41M
Net Income Margin-3.21%-5.49%15.99%34.16%35.36%39.56%40.15%31.96%27.55%17.90%
R&D6.77M7.01M13.81M21.68M29.99M51.91M65.96M93.64M107.20M95.65M
R&D as % of Total Revenue15.55%9.37%10.88%11.10%10.98%11.99%11.38%9.85%7.60%6.45%
Interest Expense1.15M1.79M1.68M221.08K60.42K826.55K2.12M9.98M20.96M22.98M
Interest Expense % of Total Revenue2.65%2.39%1.32%0.11%0.02%0.19%0.37%1.05%1.49%1.55%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets233.39M276.06M586.45M685.78M1.64B2.05B2.24B3.06B3.50B3.89B
Total Liabilities45.88M77.62M32.59M38.26M90.89M307.46M324.30M705.85M862.71M917.65M
Total Equity187.21M198.44M550.87M617.56M1.52B1.67B1.86B2.13B2.41B2.79B
Cash42.79M31.85M67.87M196.33M536.84M472.87M354.90M536.66M363.90M629.81M
Total Debt17.93M41.76M7.71M894.45K2.77M154.85M162.79M390.06M579.07M-
Net Debt-24.86M9.91M-60.16M-195.43M-534.07M-318.02M-192.11M-146.60M215.18M-

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.37M4.15M31.82M50.49M123.35M219.30M250.13M226.27M347.75M369.15M
Investing Cash Flow-36.56M-33.57M-272.21M63.98M-587.71M-420.37M-307.84M19.02M-613.76M-
Financing Cash Flow71.88M18.48M276.42M14.90M804.73M137.74M-65.07M-63.57M98.12M-
Capital Expenditure27.62M31.53M71.81M141.61M118.73M311.22M271.03M370.34M329.48M123.14M
Free Cash Flow-30.99M-27.38M-39.99M-91.12M4.62M-91.92M-20.90M-157.72M18.27M246.01M
Dividends Paid998.63K1.24M818.74K265.00K12.97K29.44M38.92M61.37M70.56M89.46M
FCF to OCF920.20%-659.78%-125.66%-180.45%3.75%-41.92%-8.36%-69.71%5.25%66.64%
Dividend Paid to FCF-3.22%-4.53%-2.05%-0.29%0.28%-32.03%-186.21%-38.91%386.18%36.36%

Earnings

Report DateAug 25, 2020Oct 27, 2020Apr 20, 2021Aug 17, 2021Oct 27, 2021Feb 23, 2022Apr 20, 2022Aug 17, 2022Oct 25, 2022Feb 14, 2023Apr 18, 2023Aug 17, 2023Oct 25, 2023Feb 6, 2024Apr 17, 2024Jun 30, 2024Oct 29, 2024Feb 6, 2025Apr 22, 2025Aug 27, 2025Oct 29, 2025Feb 27, 2026Apr 22, 2026Aug 25, 2026
EPS Estimate-----0.290.300.590.310.26-0.850.560.540.560.460.540.290.310.590.660.610.530.61
EPS Actual0.320.320.340.530.470.300.280.610.370.130.750.810.450.500.540.560.560.360.450.620.39-0.140.460.48
Surprise-----3.45%-6.67%3.39%19.35%-50.00%--4.71%-19.64%-7.41%-3.57%21.74%3.70%24.14%45.16%5.08%-40.91%-122.95%-13.21%-21.31%
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap7.51B
Enterprise Value8.15B
Trailing P/E31.80
Forward P/E0.00
Price / Sales4.61
Price / Book2.64
EPS1.22
Book Value14.92
Revenue (TTM)1.63B
Gross Profit (TTM)988.72M
EBITDA503.84M
Profit Margin14.58%
Operating Margin21.63%
Return on Equity6.99%
Return on Assets4.85%
Shares Outstanding193.44M
Shares Float142.49M
Beta0.20
Dividend Yield0.82%
Dividend Rate0.32
Payout Ratio26.89%

Dividends

20261×
0.32Jun 22, 2026
20251×
0.35Jul 18, 2025
20241×
0.27Jun 5, 2024
20231×
0.28May 23, 2023
20221×
0.21Jul 27, 2022
20211×
0.16May 26, 2021

Stock Splits

  • Jun 5, 20241.8:1